T1	Entity 0 5	CYP3A
T2	SNP 6 15	variation
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Association 65 69	risk
E1	Association:T3 bc:T4 snp_int:T2
T4	Cancer 51 64	breast cancer
A1	SNP_Class T2 Common_variant
T5	Organic_inorganic_molecules_affected 39 45	levels
E2	Organic_inorganic_molecules_affected:T5 Theme:T6 Agent:T2
T6	Entity 31 38	estrone
T7	Entity 17 30	premenopausal
R2	Risk_Factor Arg1:T2 Arg2:T7	
T8	Spec 210 221	to identify
T9	SNP 229 237	variants
A2	SNP_Class T9 Common_variant
T10	Entity 241 246;259 294	genes sex steroid synthesis or metabolism
R3	SNP_coupled_gene Arg1:T9 Arg2:T10	
T11	Organic_inorganic_molecules_affected 328 334	levels
E3	Organic_inorganic_molecules_affected:T11 Theme:T12 Agent:T9
T12	Entity 320 327	hormone
T13	Association 343 347	risk
E4	Association:T13 bc:T14 snp_int:T9
T14	Cancer 351 364	breast cancer
T15	Entity 368 381	premenopausal
T16	Entity 382 387	women
R4	Speculation_marker Arg1:E4 Arg2:T8	
R5	Risk_Factor Arg1:T9 Arg2:T15	
R6	Population_assignment Arg1:T9 Arg2:T16	
T17	SNP 684 694	rs10273424
T18	Spec 708 714	tested
T19	Association 719 730	association
E5	Association:T19 snp_int:T17 bc:T22
R7	Speculation_marker Arg1:E5 Arg2:T18	
T20	Entity 577 590	premenopausal
T21	Entity 591 596	women
R8	Risk_Factor Arg1:T17 Arg2:T20	
R9	Population_assignment Arg1:T17 Arg2:T21	
T22	Cancer 748 761	breast cancer
T24	Entity 962 967	CYP3A
T25	Entity 942 960	cytochrome P450 3A
R10	Equiv Arg1:T24 Arg2:T25	
T26	Entity 917 934	50 kb centromeric
T27	Entity 996 1002	7q22.1
T28	Association 1162 1166	risk
E6	Association:T28 bc:T34 snp_int:T36
T29	Effect_Type 1032 1041	reduction
T30	Entity 1045 1048	E1G
T31	Organic_inorganic_molecules_affected 1049 1055	levels
E7	Organic_inorganic_molecules_affected:T31 Theme:T30 Agent:T36
A3	Effect_Type E7 Decrease
R15	Effect_type_marker Arg1:E7 Arg2:T29	
T32	Level 1138 1144	modest
T33	Effect_Type 1145 1154	reduction
A4	Effect_Type E6 Decrease
A5	Level E6 Low
R16	Effect_type_marker Arg1:E6 Arg2:T33	
R17	Level_marker Arg1:E6 Arg2:T32	
T34	Cancer 1170 1183	breast cancer
T35	Entity 1170 1183;1210 1245	breast cancer diagnosed at or before age 50 years
T36	SNP 880 890	rs10273424
R14	Risk_Factor Arg1:T36 Arg2:T35	
R18	SNP_location Arg1:T36 Arg2:T26	
R19	SNP_coupled_gene Arg1:T36 Arg2:T25	
R20	SNP_location Arg1:T36 Arg2:T27	
T37	SNP 880 890	rs10273424
R21	SNP_location Arg1:T37 Arg2:T26	
R22	SNP_coupled_gene Arg1:T37 Arg2:T25	
R23	SNP_location Arg1:T37 Arg2:T27	
E8	Association:T28 snp_int:T37 bc:T34
T38	Entity 1170 1183;1320 1348	breast cancer diagnosed after age 50 years
R24	Risk_Factor Arg1:T37 Arg2:T38	
T39	Neg 1307 1310	not
T40	Level 1026 1031	21.8%
R25	Level_marker Arg1:E7 Arg2:T40	
R27	Member Arg1:T17 Arg2:T36	
R28	Member Arg1:T17 Arg2:T37	
R29	Negation_marker Arg1:E8 Arg2:T39	
R30	Effect_type_marker Arg1:E8 Arg2:T33	
R31	Level_marker Arg1:E8 Arg2:T32	
A6	Effect_Type E8 Decrease
A7	Level E8 Low
A8	SNP_Type T17 Non-Coding
A9	SNP_Type T37 Non-Coding
A10	SNP_Type T36 Non-Coding
A13	SNP_Class T36 tSNP
A14	SNP_Class T37 tSNP
A15	SNP_Class T17 tSNP
A16	Level E7 High
T23	SNP 1394 1411	Genetic variation
A11	SNP_Type T23 Non-Coding
T41	Entity 1448 1453	CYP3A
R11	SNP_coupled_gene Arg1:T23 Arg2:T41	
T42	Organic_inorganic_molecules_affected 1505 1511	levels
E9	Organic_inorganic_molecules_affected:T42 Theme:T43 Agent:T23
T43	Entity 1501 1504	E1G
T44	Entity 1487 1500	premenopausal
R12	Risk_Factor Arg1:T23 Arg2:T44	
T45	Association 1519 1529	associated
E10	Association:T45 bc:T46 snp_int:T23
T46	Cancer 1547 1560	breast cancer
T47	Entity 1564 1580	younger patients
R13	Risk_Factor Arg1:T23 Arg2:T47	
R26	Member Arg1:T23 Arg2:T36	
R32	Member Arg1:T2 Arg2:T17	
